Randomized, double-blind, placebo-controlled study of supplemental vitamin e on attenuation of the development of nitrate tolerance

Circulation

Volumn 96, Issue 8, 1997, Pages 2545-2550

  Watanabe, Hideki ^a,d   Kakihana, Masaaki ^b   Ohtsuka, Sadanori ^c   Sugishita, Yasuro ^c  

^a Kinu Medical Association Hospital   (Japan)

^b IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d KINU Medical Association Hospital   (Japan)

Author keywords

Antioxidants; Nitroglycerin; Platelets

Indexed keywords

ALPHA TOCOPHEROL; CYCLIC GMP; GLYCERYL TRINITRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030773135     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2545     Document Type: Article

References (41)

1. Abram J. Tolerance to organic nitrates. Circulation. 1986;74: 1181-1185.
2. Packer M, Lee W, Kessler P, Gottlieb S, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med. 1987;317:799-804.
3. Zimrin D, Reichek N, Bogin K, Aurigemma G, Douglas P, Berko B, Fung H-L. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation. 1988;77:1376-1384.
4. Fung H. Solving the mystery of nitrate tolerance: a new scent on the trail? Circulation. 1993;88:322-324.
5. Parker J, Farrel B, Fenton T. Cohanim M, Parker J. Counterregulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation. 1991;84:2336-2345.
6. Dupis J, Lalonde G, Lemieux R, Rouleau J. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol. 1990;16:922-931.
7. Waldman S, Rapoport R, Ginsburg R, Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol. 1986;35:3525-3531.
8. Schroder H, Leitman D, Bennett B, Waldman S, Murad F. Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. J Pharmacol Exp Ther. 1988;245:413-418.
9. Münzel T, Sayegh H, Freeman B, Tarpey M, Harrison D. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J Clin Invest. 1995;95:187-194.
10. Münzel T, Giaid A, Kurz S, Stewart D, Harrison D. Evidence for a role of endothelin-1 and protein kinase C in nitrate tolerance. Proc Natl Acad Sci U S A. 1995;92:5244-5248.
11. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr. 1991;53(suppl):314S-321S.
12. Watanabe H, Kakihana M, Ohtsuka S, Enomoto T, Yasui K, Sugishita Y. Platelet cyclic GMP: a potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance. Circulation. 1993;88:29-36.
13. Honma M, Satoh T, Takezawa J, Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small volume samples from blood and tissue. Biochem Med. 1977;18:257-273.
14. Crandall L, Leake C, Loevenhart A, Muehlberger C. Acquired tolerance to and cross-tolerance between the nitrous and nitric acid esters and sodium nitrite in man. J Pharmacol Exp Ther. 1931;41:103.
15. Elkayam U, Aronow W. Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use. Drugs. 1982;23:165-194.
16. Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med. 1991;114:667-677.
17. Mangione N, Glasser S. Phenomenon of nitrate tolerance. Am Heart J. 1994;128:137-146.
18. Münzel T, Kurz S, Heitzer T, Harrison D. New insights into mechanisms underlying nitrate tolerance. Am J Cardiol. 1996;77:24C-30C.
19. Packer M. What causes tolerance to nitroglycerin? The 100 year old mystery continues. J Am Coll Cardiol. 1990;16:932-935.
20. Slack C, McLaughlin B, Brien J, Marks G, Nakatsu K. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates. Can J Physiol Pharmacol. 1989;67:1381-1385.
21. Axelsson K, Andersson R. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol. 1983;88:71-79.
22. Needleman P, Johnson EMJ. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther. 1973;184:709-715.
23. Feelisch M, Kelm M. Biotransformation of organic nitrates to nitric oxide during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 1987;139:19-30.
24. Stephens N, Parsons A, Schofield P, Kelly F, Cheeseman K, Mitchinson M, Brown M. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
25. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H. Vitamin E deficiency in variant angina. Circulation. 1996;94:14-18.
26. Klein H, Pich S, Lindert S, Nebendahl K, Niedmann P, Kreuzer H. Combined treatment with vitamin E and C in experimental myocardial infarction in pigs. Am Heart J. 1989;118:667-673.
27. Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr. 1991;10:466-473.
28. Katz R, Levy W, Buff L, Wasserman A. Prevention of nitrate tolerance with angiotensin converting enzyme inhibitors. Circulation. 1991;83:1271-1277.
29. Muiesan M, Boni E, Castellano M, Beschi M, Cefis G, Cerri B, Verdecchia P, Porcellati C, Pollavini G, Agabiti-Rosei E. Effects of transdermal nitroglycerin in combination with an ACE-inhibitor in patients with chronic stable angina pectoris. Eur Heart J. 1993;14: 1701-1708.
30. Pizzulli L, Hagendorff A, Zirbes M, Fehske W. Ewig S, Jung W, Lüderitz B. Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation. Am Heart J. 1996;131:342-349.
31. Lawson D, Nichols W, Mehta P, Mehta J. Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE inhibitory activity. J Cardiovasc Pharmacol. 1991;17:411-418.
32. Dadak N, Makhoul N, Flugelman M, Merdler A, Shehadeh H, Schneeweiss A, Halon D, Lewis B. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1990;66:608-613.
33. Parker JD, Parker JO. Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory response during continuous therapy with nitroglyccrin. J Am Coll Cardiol. 1993;21:1445-1453.
34. Münzel T, Bassenge E. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation. 1996;93:2052-2058.
35. Parker JD, Farrell B, Fenton T. Parker JO. Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin. J Am Coll Cardiol. 1992;20:616-622.
36. Elkayam U, Kulick D. McIntosh N, Roth A, Hseuh W. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation. 1987;76:577-584.
37. Parker JD, Parker AB, Farrell B, Parker JO. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina. Circulation. 1996;93:691-696.
38. Bowen R, Haslam R. Effects of nitrovasodilators on platelet cyclic nucleotidc levels in rabbit blood: role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1. J Cardiovasc Pharmacol. 1991;17:424-433.
39. Pohl U, Busse R. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed. Circ Res. 1989;65: 1798-1803.
40. Rapoport R. Murad F. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. J Cyclic Nucleotide Pro Phosphoryl Res. 1983;9:281-296.
41. Glass D, Frey W, Carr D, Goldberg N. Stimulation of human platelet guanylate cyclase by fatty acid. J Biol Chem. 1977;252: 1279-1285.